Ariadne Labs worked with Surgo Ventures and the Post to visualize state by state vaccine distribution.
As governments and industry invest unprecedented resources in discovery and manufacturing COVID-19 vaccines, it is clear that vaccinating everyone in every corner of the globe will require even more. It will require robust delivery systems to make sure the vaccines reach the most vulnerable. And even so, for the foreseeable future, the vaccines will be in very scarce supply.
The Vaccine Delivery team at Ariadne Labs is leveraging years of studying delivery systems to identify problems in vaccine delivery and capture solutions to support health officials and decision makers with tools and evidence to allow them to plan carefully to ensure that vaccines are distributed efficiently and equitably to the people most in need.
The COVID-19 pandemic has also highlighted the need for technical advice and clear, clean data that allow decision makers to understand those who they serve. The Vaccine Delivery team at Ariadne Labs helps gather and expand access to essential data, explain how to interpret and use it, and engage intersectoral leaders to promote equitable vaccine allocation and support the use of data for good.
Resources
New York Times: Find Your Place in the Vaccine Line
A collaboration with the New York Times and Surgo Foundation using the Vaccine Allocation Planner to calculate the number of people who will need a vaccine in each state and county — and where you might fit in that line.
COVID-19 Vaccine Predictor
The Center for Global Development and Ariadne Labs have created a tool to estimate vaccine success in a variety of scenarios.
Vaccine Allocation Planner for COVID-19
When COVID-19 vaccines become available in the US, states will need to allocate them to their highest priority populations. The Vaccine Allocation Planner for COVID-19 helps state and county decision prepare for...
Modelling the Manufacturing Process for COVID-19 Vaccines: Our Approach
The Center for Global Development and Ariadne Labs have teamed up to better understand how long it will take to develop a COVID-19 vaccine and manufacture it at scale.
Vaccine Preliminary Results: Here Is Why We Need to Exercise Caution
Anthony McDonnell, Robert Van Exan, Kalipso Chalkidou, Julie Rosenberg, Rebecca Weintraub, and Prashant Yadav Much of the discussion around society’s ability to return to “normality” after the COVID-19 pandemic has...
Perspectives
News
Fortune Brainstorm: The Vaccine Rollout Is a Huge Tech Challenge
Dr. Rebecca Weintraub discusses complications with the COVID-19 vaccine rollout on Fortune's Brainstorm podcast.
USA Today: COVID-19 vaccine plan means some states will lag in getting shots to highest-risk groups
Ariadne Labs' Vaccine Allocation Planner highlighted in USA Today
Becker’s: 4 tools to predict COVID-19 death risk, place on vaccine waitlist & more
Becker's Hospital Review spotlights Ariadne Labs' Vaccine Allocation Planner.
Washington Post: Covid-19 is devastating communities of color. Can vaccines counter racial inequity?
Senior scientist Kate Miller on states' vaccine distribution plans for vulnerable populations.
FiveThirtyEight: Does It Matter Which COVID-19 Vaccine I Take?
Dr. Rebecca Weintraub discusses the variety of COVID-19 vaccines available and under development.
ABC 7: COVID Vaccine: 5 top questions about Pfizer’s coronavirus shot, answered
Dr. Rebecca Weintraub comments on equitable vaccine distribution.
Nat Geo: Who is really ‘first in line’ for the vaccine? It depends on your state.
Dr. Rebecca Weintraub in National Geographic on how states are allocating COVID-19 vaccines.
WCVB Boston: COVID-19 vaccination timeline announced for Massachusetts residents
Dr. Rebecca Weintraub joins WCVB to discuss vaccine delivery in Massachusetts.
Symposium: Vaccine Allocation and Social Justice
Ariadne Labs and partners hosted the first part of a multi-part online symposium, “Vaccine Allocation and Social Justice,” on Dec. 4 to explore concrete steps that public health leaders can take to dramatically improve...
CBS Austin: New tool figures out your place in line to get the COVID-19 vaccine
Kate Miller speaks with CBS Austin on Ariadne Labs' Vaccine Allocation Planner.
Vox: What if developing a vaccine was the easy part?
Dr. Rebecca Weintraub joins Today, Explained to discuss the challenges ahead in vaccine delivery.
BBC: What it takes to vaccinate the world
Dr. Rebecca Weintraub joins BBC's Business Daily to discuss worldwide coordination of COVID-19 vaccines.
MSNBC: Doctor calls for ‘national comprehensive plan’ on virus
Dr. Atul Gawande joins MSNBC's Morning Joe to discuss COVID-19 vaccines and national planning.
Harvard Crimson: HSPH Co-Creates Interactive Planning Tool To Aid COVID-19 Vaccine Distribution
Dr. Rebecca Weintraub explains how the Vaccine Allocation Planner for COVID-19 can help leaders prepare for vaccine distribution.
C-SPAN: Discussion on COVID-19 Vaccine Research and Development
Dr. Rebecca Weintraub joins a a virtual discussion on COVID-19 vaccine research and development.
U.S. Vaccine Allocation Planner for COVID-19 Launched by Ariadne Labs and Surgo Foundation
Data-driven tool will help state and county decisionmakers operationalize phased vaccine distribution.
POLITICO: The coronavirus vaccine race slams into reality
COVID-19 Vaccine Allocation Planner shared by POLITICO
Radio Open Source: Warped Speed
Dr. Rebecca Weintraub joins Radio Open Source to discuss the race for a COVID-19 vaccine.
HuffPost: The Vaccine Race Has Become A High-Stakes Geopolitical Gamble
Dr. Rebecca Weintraub on the need for global COVID-19 vaccine initiative.
HuffPost France: Coronavirus Vaccine Race
Dr. Rebecca Weintraub speaks about the international scramble to produce a COVID-19 vaccine.
Times Radio: Vaccine Nationalism
Dr. Rebecca Weintraub joins Times Radio UK to discuss vaccine nationalism (at ~65 minute mark)
